Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Market Size of the Implantable Cardiac Devices Market In 2029?
The market for implantable cardiac devices has experienced substantial growth in recent years. The sector is set to expand from a value of $12.34 billion in 2024 to $13.46 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.1%. This notable rise during the historical period can be traced back to factors such as advancements in medical technology, increased incidences of cardiovascular diseases, augmented elderly population, enhancements in the dependability and lifespan of devices, escalated awareness, and prompt detection of cardiac conditions.
What Growth Rate Is Forecasted for the Implantable Cardiac Devices Market by 2029?
Expectations are high for the implantable cardiac devices market, with a robust expansion in sight for the coming years. By 2029, it’s predicted the market will hit $18.81 billion, with a compound annual growth rate (CAGR) of 8.7%. This projected growth throughout the forecast period can be traced back to various factors such as technological progression in device functionality, a rise in demand for minimally invasive procedures, a growing elderly population, escalating healthcare costs, and the development of healthcare infrastructure in up-and-coming markets. Key trends during this forecast period are predicted to include the integration of digital health and remote monitoring, the creation of technologically advanced devices with enhanced features, a surge in customized cardiac solutions, a focus on cost-effectiveness and value in healthcare, a growing interest in preventative cardiology, and the emphasis on early intervention.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19097&type=smp
Which Key Companies Are Shaping the Future of the Implantable Cardiac Devices Market?
Major companies operating in the implantable cardiac devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, Biotronik SE & Co. KG, Zoll Medical Corporation, Nihon Kohden Corporation, LivaNova plc, Lepu Medical Technology, MicroPort Scientific Corporation, AtriCure Inc., LifeTech Scientific Corporation, Berlin Heart GmbH, EBR Systems Inc., Defibtech LLC, CVRx Inc., Progetti Srl, Endotronix Inc., Jarvik Heart Inc., Xeltis AG, Carmat SA, Windmill Cardiovascular Systems Inc
Which Factors Are Driving Demand in the Implantable Cardiac Devices Industry?
The growing number of heart disease cases is predicted to fuel the expansion of the market for implantable cardiac devices. The escalation in heart diseases can be traced back to the rising occurrence of risks like poor diet, inactive lifestyle, obesity, and persistent conditions such as hypertension and diabetes. Moreover, elderly populations and increasing stress levels also contribute to the amplified incidence of cardiovascular disorders. Implantable cardiac devices are employed to manage and treat conditions like heart failure, arrhythmias, and coronary artery ailments. This escalating requirement promotes innovation and investment in creating new and better cardiac devices to cater to the burgeoning patient population and enhance treatment results. For example, as per the Singapore Heart Foundation (SHF), a non-profit organization based in Singapore, ischemic heart diseases caused 5,302 deaths in May 2024, showing a minor rise from 5,290 deaths in 2022. Hence, the growing incidence of heart diseases is fueling the growth of the implantable cardiac devices market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=19097&type=smp
How Is the Implantable Cardiac Devices Market Segmented by Several Divisions?
The implantable cardiac devicesmarket covered in this report is segmented –
1) By Type: Pacemaker, Implantable Cardioverter Defibrillator (ICD), Biventricular Implantable Cardioverter Defibrillator (BI-V ICD)
2) By Application: Bradycardia, Tachycardia, Heart Failure, Other Applications
3) By End User: Hospitals, Specialty Clinics, Other End Users
Subsegments:
1) By Pacemaker: Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Rate-Responsive Pacemakers
2) By Implantable Cardioverter Defibrillator (ICD): Transvenous ICDs, Subcutaneous ICDs, Wearable Cardioverter Defibrillators
3) By Biventricular Implantable Cardioverter Defibrillator (BI-V ICD): Standard BI-V ICDs, Advanced BI-V ICDs with Cardiac Resynchronization Therapy (CRT)
What are the Emerging Market Trends Driving the Growth of the Implantable Cardiac Devices Industry?
Leading companies in the implantable cardiac devices market strive to increase compatibility with diagnostic instruments like AutoMRI to prolong the device lifespan and enhance patient safety. The AutoMRI feature in implantable cardiac defibrillators self-regulates the device settings, providing safe operation during MRI scans, improving patient care, and allowing the usage of sophisticated imaging technology. For example, in October 2023, MicroPort CRM, a medical device company based in France, introduced the ULYS implantable cardioverter defibrillator (ICD) and INVICTA defibrillation leads in Japan. These tools offer cutting-edge technology with minimal current usage for increased device lifespan and MRI compatibility. The ULYS ICD includes the PARAD+ arrhythmia discrimination algorithm and AutoMRI functionality, while the INVICTA lead offers precise pacing and defibrillation treatment with a 100% successful implantation rate and 97.4% rate free of complications during clinical trials.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/implantable-cardiac-devices-global-market-report
Which Regions Are Driving Growth in the Implantable Cardiac Devices Market?
North America was the largest region in the implantable cardiac devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable cardiac devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19097
This Report Delivers Insight On:
1. How big is the implantable cardiac devices market, and how is it changing globally?
2. Who are the major companies in the implantable cardiac devices market, and how are they performing?
3. What are the key opportunities and risks in the implantable cardiac devices market right now?
4. Which products or customer segments are growing the most in the implantable cardiac devices market?
5. What factors are helping or slowing down the growth of the implantable cardiac devices market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model